A Case of Effective Mepolizumab Induction Therapy for Severe Eosinophilic Granulomatosis with Polyangiitis Diagnosed by Eosinophilic Cholecystitis and Interstitial Nephritis.

Case Reports in Rheumatology Pub Date : 2021-06-19 eCollection Date: 2021-01-01 DOI:10.1155/2021/6678893
Keita Hattori, Yuri Teramachi, Yoshinori Kobayashi, Takeshi Ito, Takatoshi Morinaga, Hirohumi Tamai, Yoshihiro Yamamoto
{"title":"A Case of Effective Mepolizumab Induction Therapy for Severe Eosinophilic Granulomatosis with Polyangiitis Diagnosed by Eosinophilic Cholecystitis and Interstitial Nephritis.","authors":"Keita Hattori,&nbsp;Yuri Teramachi,&nbsp;Yoshinori Kobayashi,&nbsp;Takeshi Ito,&nbsp;Takatoshi Morinaga,&nbsp;Hirohumi Tamai,&nbsp;Yoshihiro Yamamoto","doi":"10.1155/2021/6678893","DOIUrl":null,"url":null,"abstract":"<p><p>A 66-year-old man with a history of bronchial asthma and sinusitis was admitted with cholecystitis and peripheral neuropathy. The histopathological findings of the gallbladder revealed necrotic vasculitis and granulomatous inflammation with marked eosinophilic infiltration. Kidney biopsy also showed marked eosinophilic infiltration in the tubulointerstitial area and eosinophilic tubulitis. He was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA) and treated with corticosteroids. However, he showed no response. Therefore, he was administered mepolizumab 300 mg, which resulted in clinical improvement, including normalization of the eosinophil and CRP levels. We herein describe the first case of successful induction therapy of EGPA using mepolizumab.</p>","PeriodicalId":9622,"journal":{"name":"Case Reports in Rheumatology","volume":"2021 ","pages":"6678893"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235979/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/6678893","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

A 66-year-old man with a history of bronchial asthma and sinusitis was admitted with cholecystitis and peripheral neuropathy. The histopathological findings of the gallbladder revealed necrotic vasculitis and granulomatous inflammation with marked eosinophilic infiltration. Kidney biopsy also showed marked eosinophilic infiltration in the tubulointerstitial area and eosinophilic tubulitis. He was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA) and treated with corticosteroids. However, he showed no response. Therefore, he was administered mepolizumab 300 mg, which resulted in clinical improvement, including normalization of the eosinophil and CRP levels. We herein describe the first case of successful induction therapy of EGPA using mepolizumab.

Abstract Image

Abstract Image

Abstract Image

Mepolizumab诱导治疗嗜酸性胆囊炎和间质性肾炎诊断为多血管炎的严重嗜酸性肉芽肿病1例
66岁男性,有支气管哮喘和鼻窦炎病史,因胆囊炎和周围神经病变入院。胆囊的组织病理学结果显示坏死血管炎和肉芽肿性炎症,伴有明显的嗜酸性粒细胞浸润。肾活检也显示在小管间质区有明显的嗜酸性粒细胞浸润和嗜酸性小管炎。他被诊断为嗜酸性肉芽肿病伴多血管炎(EGPA),并接受皮质类固醇治疗。然而,他没有任何反应。因此,他被给予mepolizumab 300mg,这导致临床改善,包括嗜酸性粒细胞和CRP水平正常化。我们在此描述的第一例成功的诱导治疗的EGPA使用mepolizumab。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
35
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信